PADA

PADA: sourced facts only. name: "[111In]In-PADA exhibited marked binding ability to albumin, PSMA, and GRPR in vitro." [PMID:42447187]; target: "[111In]In-PADA exhibited marked binding ability to albumin, PSMA, and GRPR in vitro." [PMID:42447187]; target: "[111In]In-PADA exhibited marked binding ability to albumin, PSMA, and GRPR in vitro." [PMID:42447187]; developer: "Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-Ku, Kyoto606-8501, Japan." [PMID:42447187]; stage: "In single-photon emission computed tomography (SPECT) imaging studies, [111In]In-PADA could be used to successfully visualize both PSMA-positive and GRPR-positive tumors and exhibited enhanced tumor-to-kidney contrast due to the introduction of ALB." [PMID:42447187]